Pharmafile Logo

How to elevate your communications testing with AI powered insights and analytics

Learn about a new behavioural science-led framework incorporating AI technologies that ensures you get a true reflection of how your communications materials are consumed and processed by customers

Pharmaceutical companies strive to develop the most effective communication assets for their brands in order to maximise their impact. The challenge though is in identifying the messages and concepts that will have the greatest impact and influence with customers.

While there is now an appreciation of the subconscious behavioural biases that influence how we respond to marketing, many pharmaceutical companies are still developing and testing the majority of their communication campaigns based on more traditional insight gathering.

At Research Partnership, we have developed a behavioural science-led framework incorporating new AI technologies that ensures you get a true reflection of how your communications materials are consumed and processed by customers. watch this webcast to learn about the various components of this new approach and how each of them offered complementary benefits for a recent client who was looking to evaluate their creative concepts.

What you will learn

  • How innovative new technologies can complement traditional research techniques to provide a truer, multi-dimensional picture of how marketing communications perform with the target audience
  • How a new, behavioural science-led approach to communications research can take into account both instinctive and considered thinking as well as other behavioural biases to provide a more holistic evaluation of marketing materials
  • How to make use of AI, facial analysis and implicit response techniques to gain a 360-degree view of communications performance and how this can overcome the limitations of conducting market research remotely in a post-pandemic era

Watch the webcast

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Research conducted for Johnson and Johnson published in scientific journal

Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, has been published in Clinical Genitourinary Cancer.

Connecting our Inizio Advisory capabilities to help a client address a threat to the brand, guide strategy and improve brand performance

The challenge Our client knew that prescribing of a key brand in a major market had slowed and needed to understand which patient segments were impacted so they could address...

Autoimmune conditions: Living With syndicated patient reports

The prevalence of autoimmune conditions is increasing, and despite significant advancements in treatments, individuals affected by these diseases may not be receiving the most effective management and care. In our...

How we elevated HCP market research engagement and insights using AI avatars for an immersive experience

Our client required an effective strategy for promoting discussions about self-paid vaccines with healthcare professionals (HCPs) during patient consultations. The conventional method of conducting market research would typically only deliver...

How we provided comprehensive real-world patient data for PAH using Therapy Watch, our syndicated market tracking solution

PAH is a specific type of pulmonary hypertension, which is a rare condition treated primarily in specialized centers. Our client needed to gain a comprehensive understanding of PAH patients, such...

Latest European developments and new talent at Research Partnership

Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its...

New syndicated report – Living with Ulcerative Colitis 2024

Living with Ulcerative Colitis (UC) is a new syndicated patient report that presents valuable insights into the unmet needs and the burden experienced by patients living with UC. The report...

Webcast: AI in MRX: Harnessing the power of AI + people

Artificial intelligence (AI) in market research has surged in recent years, with a flow of innovative tools and techniques which have the potential to revolutionize the landscape. But to unlock...

Navigating challenges of MedTech research with rare-disease patients

Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.